Full Press Release Details
Concord Healthcare Announces Official Release
of the Proton Therapy Large Model
BEIJING, May 29, 2025 /PRNewswire/ -- Concord Healthcare
Group Co., Ltd. ("Concord Healthcare"), a subsidiary of Concord Medical Services Holdings Limited (the "Company")
(NYSE: CCM), which subsidiary is listed on the Main Board of The Stock Exchange of Hong Kong Limited (the "HKSE") under the
stock code 2453.HK, announced that Concord Healthcare had made important progress in precise tumor diagnosis and treatment technology.
Concord Healthcare's self-developed large language model ("LLM") in the vertical field of proton therapy was officially
released and successfully deployed in Guangzhou Concord Cancer Hospital. Since the commencement of the proton therapy in Guangzhou Concord
Cancer Hospital, the proton therapy has completed a number of high-quality patient treatment cases, demonstrating the outstanding advantages
of precise treatment, significant efficacy, and reduced side effects.
Concord Healthcare's proton LLM is the first LLM focusing on
proton therapy in China, and its research and development relies on the tumor diagnosis and treatment technology system and massive data
accumulated by Concord Healthcare over the years. It integrates nearly 10,000 high-quality radiotherapy cases to construct multimodal
medical data, and also integrates data from Proton China and professional journal literature to achieve enhancement of model training.
The Company previously announced the listing of Concord Healthcare's
H shares on the HKSE on January 9, 2024. The information related to Concord Healthcare's Transactions on the HKSE is accessible
through the HKSE's website at www.hkexnews.hk.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare provider
featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses
on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with
technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality
and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China.
For more information, please see http://ir.ccm.cn.
About Concord Healthcare
Concord Healthcare is an oncology healthcare provider in China. Concord
Healthcare serves both cancer patients through self-owned medical institutions and third-party medical institutions through medical
equipment, software and related services. In its self-owned medical institutions, Concord Healthcare provides a full spectrum of oncology
healthcare services to cancer patients across the entire care continuum, leveraging its multidisciplinary team specialists and diagnosis
and treatment capabilities featuring precision radiation therapy. Through its medical equipment, software and related services, Concord
Healthcare serves a widespread network of enterprise customers, primarily hospitals, with integrated oncology-related services, including
primarily sales and installing of medical equipment and software, management and technical support, and operating lease.
Safe Harbor Statement
This announcement contains forward-looking statements. These forward-looking
statements can be identified by words or phrases such as "will," "expects," "anticipates," "future,"
"intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements
are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future
business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those
contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except
as required under applicable law.
For more information, please contact:
Concord Medical Services Holdings Limited